Singapore: Non-Small Cell Lung Cancer (NSCLC) treatment pipeline has a diverse selection of 122 first-in-class products ...
Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials o...
Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatiti...
Singapore: AMRI has completed the acquisition of Cedarburg Pharmaceuticals, a contract developer and manufacturer of tec...
Singapore: Researchers from Shanghai Institute of Materia Medica, Chinese Academy of Science, have discovered that Latan...
Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...
Singapore: Eli Lilly has partnered with German firm, BioNTech, to discover novel cancer immunotherapies through body's o...
Singapore: Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows o...
Singapore: Indian pharma company Cadila Healthcare that operates under the aegis of Zydus Group, has launched its patent...
Singapore: Astellas Pharma has obtained the marketing approval of Irribow OD 1 Tablets 2.5µg / 5µg (generic name: ramo...
Singapore: Biotron, a clinical-stage drug development company focused on development of new generation antiviral drugs, ...
After geting the regulatory approval in early 2013, Biocon, India's number two biotech company by revenues, released the...
Singapore: Bioventus, which specializes in active orthopaedic healing, has acquired exclusive, worldwide license to Pfiz...
Singapore: Merck, known as Merck Sharp & Dohme (MSD) outside the US and Canada, provided update on its clinical prog...
Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...
Singapore: Oramed Pharmaceuticals, developer of oral drug delivery systems, submitted a pre-investigational new drug (pr...
Singapore: GE Healthcare Life Sciences has licensed Cellular Dynamics International, US-based commercial producer of hum...
